Transcriptional splice variants of CD40 and its prognostic value in breast cancer.

Ünver, Nese; Yöyen Ermis, Digdem; Weber, Bahar Zehra; Esendagli, Günes

Ünver, Nese; Yöyen Ermis, Digdem; Weber, Bahar Zehra; Esendagli, Günes.

Afiliación

Ünver N; Department of Stem Cell Sciences, Graduate School of Health Sciences, Center for Stem Cell Research and Development,Hacettepe University, Ankara Turkey.
Yöyen Ermis D; Department of Medical Biology, Faculty of Medicine, Lokman Hekim University, Ankara Turkey.
Weber BZ; Institute of Cancer Research, Medical University of Vienna, Vienna Austria.
Esendagli G; Department of Basic Oncology, Cancer Institute, Hacettepe University, Ankara Turkey.

Turk J Biol ; 44(2): 73-81, 2020.

Article en En | MEDLINE | ID: mdl-32256143

Palabras clave

CD4; alternative splicing; antitumor response; breast cancer; transcriptional variant

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Turk J Biol Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Turk J Biol Año: 2020 Tipo del documento: Article